Salute e Benessere
Ajinomoto Bio-Pharma Services and Olon S.p.A. Form Strategic Partnership to Advance Large-Scale Peptide and Protein Manufacturing
This collaboration combines Aji Bio-Pharma's expertise in microbial strain and process development with Olon's large-scale GMP manufacturing expertise utilizing fermenters with a capacity of over 100,000 liters. The partnership will accelerate productive and sustainable manufacturing of high-demand proteins and peptides such as GLP-1 analogs which play a critical role in treating obesity and Type II diabetes.
said Yasuyuki Otake , Corporate Executive, General Manager, Bio-Pharma Services Dept., Ajinomoto Co., Inc. Andrea Conforto , S&M – VP CDMO Biotech, Olon S.p.A., added,
said Yasuyuki Otake and Andrea Conforto .
CORYNEX , based on the gram-positive bacteria , can drastically streamline the manufacturing process since it can secrete soluble and biologically active targets directly into the media with high titers and purity, is scalable, fast-growing, non-endotoxic, non-pathogenic, non-sporulating, and doesn't require an expression inducer like IPTG or methanol. Olon combines extensive expertise in microbial fermentation for CDMO and proprietary products, including high-potent or toxic compounds using high-containment systems. With fermenters ranging from 1–255 m³ and a total capacity of 5,000 m³, Olon is one of
Europe's largest third-party microbial fermentation producers.
Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium , United States , Japan , and India , providing support across gene therapy, APIs, and both large and small molecule manufacturing. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including high potency APIs (HPAPI), continuous flow manufacturing, oligonucleotide synthesis, biocatalysis, Corynex protein expression technology, antibody drug conjugations (ADC) and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet our clients' needs. Learn more: www.AjiBio-Pharma.com.
Olon is an Italian company specializing in the development and production of active pharmaceutical ingredients (APIs), combining expertise in chemical synthesis and biological processes. Headquartered in Rodano ( Milan, Italy ), Olon operates 14 manufacturing sites and 14 R&D centers worldwide, with over 2,800 employees. With decades of experience, the company provides end-to-end support, from early development to commercial manufacturing, while maintaining a strong commitment to innovation, sustainability, and quality. For more information, visit www.olonspa.com.
For further information, please contact: HERE
Logo - https://mma.prnewswire.com/media/751177/Aji_BioPharma_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/ajinomoto-bio-pharma-services-and-olon-spa-form-strategic-partnership-to-advance-large-scale-peptide-and-protein-manufacturing-302596157.html